Jove
Visualize
Contact Us

Related Concept Videos

Metastasis02:30

Metastasis

6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

2.5K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
2.5K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer clinical trial recruitment for patients from rural areas: a scoping review.

International journal for equity in health·2026
Same author

Closing the gap of older adult recruitment to cancer clinical trials: a scoping review.

BMC cancer·2026
Same author

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.

Cancer metastasis reviews·2026
Same author

iRECIST: A Case Based Users Guide for Radiologists.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same author

Global variations in oncology professionals' confidence levels for managing antibody-drug conjugate toxicities: a cross-continental survey.

The oncologist·2025
Same author

Steroid-Induced Mental Disorders in Oncology Patients: A 10-Year Retrospective Case Series Review.

Psycho-oncology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 8, 2025

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

5.9K

Dural spread from metastatic prostate cancer.

Niamh Peters1, Mohammed Zeeshan Zeeshan Zemeer2, Conor Waters3

  • 1Medical Oncology, Cork University Hospital, Cork, Ireland niamhpeters27@gmail.com.

BMJ Case Reports
|April 28, 2021
PubMed
Summary

A patient with metastatic prostate cancer and a BRCA1 mutation experienced a sudden neurological decline. This was caused by prostate cancer dural metastases, highlighting the aggressive nature of advanced disease.

Keywords:
neurooncologyprostate cancerradiotherapy

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.5K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.7K

Related Experiment Videos

Last Updated: Nov 8, 2025

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

5.9K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.5K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.7K

Area of Science:

  • Oncology
  • Neurology
  • Genetics

Background:

  • Advanced prostate cancer with bone and lymph node metastases.
  • Patient had a known breast cancer gene 1 (BRCA1) mutation.
  • Treatment included the poly ADP ribose polymerase (PARP) inhibitor Rucaparib.

Observation:

  • Sudden onset of thunderclap headache, photophobia, and left facial droop.
  • Recent diagnosis of malignant spinal cord compression (T3-T6) requiring surgery and radiotherapy.
  • CT brain revealed dural metastases with significant cerebral edema and midline shift.

Findings:

  • Prostate cancer had metastasized to the dura mater of the brain.
  • Neurological symptoms were attributed to leptomeningeal carcinomatosis.
  • The patient's condition rapidly deteriorated despite palliative whole brain radiotherapy.

Implications:

  • Highlights the potential for aggressive leptomeningeal spread in advanced prostate cancer, even with PARP inhibitor therapy.
  • Underscores the importance of prompt neurological evaluation in patients with metastatic cancer presenting with acute neurological symptoms.
  • Suggests a need for further research into the mechanisms and management of dural metastases in prostate cancer.